Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3095196 29 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background: Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and is implicated in the development of diabetic microvascular and macrovascular disease. Methods: The expression of total VEGF, VEGF splice variants (VEGF121, VEGF145, VEGF148, VEGF165, VEGF183 and VEGF189), VEGFR-1 and VEGFR-2, was investigated in biopsies from the right atrium and left internal mammary artery (LIMA) of 32 non-diabetic and 20 diabetic patients undergoing coronary artery bypass grafting. Results: Diabetes was independently negatively correlated to total VEGF mRNA expression in atrium. Total VEGF, VEGF121 and VEGF165 mRNA levels were upregulated in the LIMA of diabetics vs. non-diabetics. The expression of VEGF receptors in atrium and LIMA was similar between these groups. VEGF121 and VEGF165 were the major variants expressed, followed by VEGF189 and VEGF183, while VEGF148 and VEGF145 were detected in small amounts. The expression profile of VEGF splice variants displayed significant heterogeneity between the examined tissues. Conclusions: This is the first study to quantify VEGF splice variants expression in cardiac and vascular tissue. Our results could help elucidate the role of VEGF splice variants in diabetic complications. © 2007 The Canadian Society of Clinical Chemists.
Έτος δημοσίευσης:
2008
Συγγραφείς:
Zygalaki, E.
Kaklamanis, L.
Nikolaou, N.I.
Kyrzopoulos, S.
Houri, M.
Kyriakides, Z.
Lianidou, E.S.
Kremastinos, D.Th.
Περιοδικό:
Clinical Biochemistry
Τόμος:
41
Αριθμός / τεύχος:
1-2
Σελίδες:
82-87
Λέξεις-κλειδιά:
messenger RNA; unclassified drug; vasculotropin 121; vasculotropin 145; vasculotropin 148; vasculotropin 165; vasculotropin 183; vasculotropin 189; vasculotropin receptor; vasculotropin receptor 1; vasculotropin receptor 2, adult; aged; article; clinical article; controlled study; coronary artery bypass graft; coronary artery disease; diabetes mellitus; female; gene expression; genetic heterogeneity; heart right atrium; human; internal mammary artery; male; priority journal; protein expression; upregulation; vascularization, Aged; Alternative Splicing; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Gene Expression Profiling; Heart Atria; Humans; Male; Mammary Arteries; Middle Aged; Myocardium; Protein Isoforms; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Vascular Endothelial Growth Factor A
Επίσημο URL (Εκδότης):
DOI:
10.1016/j.clinbiochem.2007.09.005
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.